P-ISSN 2575-3819
E-ISSN 2575-3827
Vol. 20, Issue 2, 2013January 01, 2013 EDT
A Pharmaceutical Park Place: Why the Supreme Court Should Modify the Scope of the Patent Test for Reverse Payment Deals
A Pharmaceutical Park Place: Why the Supreme Court Should Modify the Scope of the Patent Test for Reverse Payment Deals
David Ernest Balajthy,
patentreverse paymentpharmaceuticalspay-for-delayIn re Tamoxifen Antitrust Litigationscope-of-the-patent testFederal Trade CommissionDrug Price Competition and Patent Term Restoration Act of 1984Hatch-Waxman ActFDAANDAprimary patentssecondary patentsTamoxifenZeneca
Articles in Vol. 20, Issue 2, 2013
Vol. 20, Issue 2, 2013
- Evil Angel Eulogy: Reflections on the Passing of the Obscenity Defense in CopyrightJames R. Alexander
- A Pharmaceutical Park Place: Why the Supreme Court Should Modify the Scope of the Patent Test for Reverse Payment DealsDavid Ernest Balajthy
- A "Sunbeam" of Hope: The Seventh Circuit's Solution Overcoming Disparaging Treatment to Trademark Licenses Under the Bankruptcy CodeJarrod N. Cone
- Rants and Raves: Craigslist's Attempt to Stop Innovating Third-Party Web Developers with Copyright LawStephanie Marie Davies
- Just You and Me and Netflix Makes Three: Implications for Allowing "Frictionless Sharing" of Personally Identifiable Information Under the Video Privacy Protection ActKathryn Elizabeth McCabe
David Ernest Balajthy, A Pharmaceutical Park Place: Why the Supreme Court Should Modify the Scope of the Patent Test for Reverse Payment Deals, 20 Ga J.L. & Tech. 315 (2013).